Anticorpi e Prodotti Correlati Fc
Santa Cruz Biotechnology ofrece una gran variedad de anticuerpos Fc para diversas aplicaciones de investigación. Los anticuerpos monoclonales Fc se utilizan ampliamente en western blotting (WB), inmunoprecipitación (IP), inmunofluorescencia (IF), inmunohistoquímica con secciones incluidas en parafina (IHCP), citometría de flujo (FCM) y ensayo inmunoenzimático (ELISA). Los anticuerpos Fc desempeñan un papel crucial en la respuesta inmunitaria al unirse a la región Fc de las inmunoglobulinas, facilitando las interacciones con los receptores Fc de las células inmunitarias. Esta interacción es esencial para procesos como la citotoxicidad celular dependiente de anticuerpos (ADCC) y la fagocitosis, por lo que los anticuerpos Fc son importantes tanto en la investigación básica como en las aplicaciones terapéuticas. El conocimiento de la función de los anticuerpos Fc aporta información valiosa sobre la regulación inmunitaria y el desarrollo de terapias basadas en anticuerpos. Los anticuerpos Fc permiten a los investigadores explorar mecanismos complejos del sistema inmunitario y vías de señalización celular. La investigación de las respuestas mediadas por Fc ayuda a avanzar en el conocimiento de los trastornos autoinmunes, la inmunoterapia del cáncer y el desarrollo de vacunas. La especificidad y fiabilidad de los anticuerpos Fc monoclonales de Santa Cruz Biotechnology ayudan a los investigadores de todo el mundo a realizar contribuciones significativas a la investigación inmunológica y al desarrollo terapéutico.
VEDI ANCHE...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
Fc Anticorpi
| Empty Table Header | Nome del prodotto | CATALOG # | Isotipo | Epitopo | Applicazione | Species | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|---|
Fc ε RIα Anticorpo (X-22) | sc-100279 | mouse IgG1 κ | 1-258 (h) | WB, IP, ELISA | h | 2 | ||
Fc ε RIα Anticorpo (1F2A9) | sc-517280 | mouse IgG1 κ | 42-103 (h) | WB, IF, IHC(P), FCM, ELISA | h | new | ||
Fc ε RIβ Anticorpo (5-RE9) | sc-134340 | mouse IgG2a κ | 1-60 (h) | WB, IP, ELISA | h | new | ||
Fc ε RIβ Anticorpo (F-1) | sc-393789 | mouse IgG2b κ | 1-21 (m) | WB, IP, IF, ELISA | m, r | 2 | ||
Fc ε RIβ Anticorpo (H-5) | sc-398863 | mouse IgG2b κ | 111-235 (m) | WB, IP, IF, ELISA | m, r, h | 4 | ||
Fc ε RIγ Anticorpo (E-12) | sc-390222 | mouse IgG2a κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
Fc ε RIγ Anticorpo (A-5) | sc-374335 | mouse IgG2a κ | 51-85 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc ε RIγ Anticorpo (F-1) | sc-390221 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Fc ε RIγ Anticorpo (G-3) | sc-390246 | mouse IgM κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc ε RIγ Anticorpo (H-5) | sc-374385 | mouse IgG1 κ | 51-85 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc γ RIIb Anticorpo (RR05) | sc-73817 | rat IgG2a | 40-217 (m) | WB, IP (non-reducing), ELISA | m, r, h | new |
Fc CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
Fc ε RIα Plasmide KO CRISPR/Cas9 (h) | sc-416948 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIα Plasmide HDR (h) | sc-416948-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIα Plasmide Double Nickase (h) | sc-416948-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα Plasmide Double Nickase (h2) | sc-416948-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα Plasmide KO CRISPR/Cas9 (m) | sc-420301 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIα Plasmide HDR (m) | sc-420301-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIα Plasmide Double Nickase (m) | sc-420301-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα Plasmide Double Nickase (m2) | sc-420301-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Plasmide KO CRISPR/Cas9 (h) | sc-418526 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIβ Plasmide HDR (h) | sc-418526-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIβ Plasmide Double Nickase (h) | sc-418526-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Plasmide Double Nickase (h2) | sc-418526-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Plasmide KO CRISPR/Cas9 (m) | sc-420302 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIβ Plasmide HDR (m) | sc-420302-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIβ Plasmide Double Nickase (m) | sc-420302-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Plasmide Double Nickase (m2) | sc-420302-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Plasmide KO CRISPR/Cas9 (h) | sc-417621 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIγ Plasmide HDR (h) | sc-417621-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIγ Plasmide Double Nickase (h) | sc-417621-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Plasmide Double Nickase (h2) | sc-417621-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Plasmide KO CRISPR/Cas9 (m) | sc-420303 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIγ Plasmide Double Nickase (m) | sc-420303-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Plasmide Double Nickase (m2) | sc-420303-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc γ RIII Plasmide KO CRISPR/Cas9 (m) | sc-420307 | m | Gene Knockout | GFP | 0 | ||
Fc γ RIII Plasmide HDR (m) | sc-420307-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc γ RIII Plasmide Double Nickase (m) | sc-420307-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc γ RIII Plasmide Double Nickase (m2) | sc-420307-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Fc CRISPR Activation Products
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
Fc ε RIα Plasmide di attivazione CRISPR (h) | sc-416948-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Plasmide di attivazione CRISPR (h2) | sc-416948-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Particelle di Attivazione Lentivirale (h) | sc-416948-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Particelle di Attivazione Lentivirale (h2) | sc-416948-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Plasmide di attivazione CRISPR (m) | sc-420301-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Plasmide di attivazione CRISPR (m2) | sc-420301-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Particelle di Attivazione Lentivirale (m) | sc-420301-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Particelle di Attivazione Lentivirale (m2) | sc-420301-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Plasmide di attivazione CRISPR (h) | sc-418526-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Plasmide di attivazione CRISPR (h2) | sc-418526-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Particelle di Attivazione Lentivirale (h) | sc-418526-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Particelle di Attivazione Lentivirale (h2) | sc-418526-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Plasmide di attivazione CRISPR (m) | sc-420302-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Plasmide di attivazione CRISPR (m2) | sc-420302-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Particelle di Attivazione Lentivirale (m) | sc-420302-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Particelle di Attivazione Lentivirale (m2) | sc-420302-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Plasmide di attivazione CRISPR (h) | sc-417621-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Plasmide di attivazione CRISPR (h2) | sc-417621-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Particelle di Attivazione Lentivirale (h) | sc-417621-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Particelle di Attivazione Lentivirale (h2) | sc-417621-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Plasmide di attivazione CRISPR (m) | sc-420303-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Plasmide di attivazione CRISPR (m2) | sc-420303-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Particelle di Attivazione Lentivirale (m) | sc-420303-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Particelle di Attivazione Lentivirale (m2) | sc-420303-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Plasmide di attivazione CRISPR (m) | sc-420307-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Plasmide di attivazione CRISPR (m2) | sc-420307-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Particelle di Attivazione Lentivirale (m) | sc-420307-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Particelle di Attivazione Lentivirale (m2) | sc-420307-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Fc siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
Fc &epsilon RIβ Plasmide shRNA (h) | sc-45264-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ shRNA (h) Particelle lentivirali | sc-45264-V | h | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ Plasmide shRNA (m) | sc-45265-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ shRNA (m) Particelle lentivirali | sc-45265-V | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (h) | sc-45258 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIα Plasmide shRNA (h) | sc-45258-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα shRNA (h) Particelle lentivirali | sc-45258-V | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (m) | sc-45259 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIα Plasmide shRNA (m) | sc-45259-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα shRNA (m) Particelle lentivirali | sc-45259-V | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (r) | sc-270639 | r | Gene Silencing | N/A | 0 | ||
Fc ε RIα Plasmide shRNA (r) | sc-270639-SH | r | Gene Silencing | N/A | 0 | ||
Fc ε RIα shRNA (r) Particelle lentivirali | sc-270639-V | r | Gene Silencing | N/A | 0 | ||
Fc ε RIβ siRNA (h) | sc-45264 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIβ siRNA (m) | sc-45265 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIγ siRNA (h) | sc-45267 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIγ Plasmide shRNA (h) | sc-45267-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ shRNA (h) Particelle lentivirali | sc-45267-V | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ siRNA (m) | sc-45268 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIγ Plasmide shRNA (m) | sc-45268-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ shRNA (m) Particelle lentivirali | sc-45268-V | m | Gene Silencing | Puromycin | 0 | ||
Fc γ RIII siRNA (m) | sc-145145 | m | Gene Silencing | N/A | 0 | ||
Fc γ RIII Plasmide shRNA (m) | sc-145145-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc γ RIII shRNA (m) Particelle lentivirali | sc-145145-V | m | Gene Silencing | Puromycin | 0 |